Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs.
S. Vignes(Sorbonne Université), J.C. Piette(Sorbonne Université), P Godeau(Normandie Université), D. Lê Thi Huong(Sorbonne Université), P Veyssier, Zahir Amoura(Inserm), Beat Wechsler, C. Françès(Navarre Institute of Health Research), T. Papo(Assistance Publique – Hôpitaux de Paris)
PubMed
August 24, 1998
Cited by 73
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
|The Lancet Rheumatology|2021|292
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262